Featured JAX® Mice for Cancer Research
Browse the most popular and newly emerging models for the study of human cancer including induced, transgenic, and conditional mouse models.
The Jackson Laboratory provides the most widely published and cutting-edge models for oncology research and offers a comprehensive suite of solutions for your oncology research needs.
Over 400 patient-derived xenograft (PDX) tumors are available for engrafting into immunocompromised NSG™ mice for shipment to your facility or use in JAX-directed preclinical efficacy studies.
A robust immuno-oncology platform for efficacy testing of novel immunotherapies targeting T cells and myeloid cells.
This webinar highlights recent advances and future directions using xenografted humanized NSG™ mice with functional human immune cells, to evaluate cancer immunotherapies.
Join us as our guest speaker, Rebecca Larson, Ph.D., from Massachusetts General Hospital, discusses her publication “CAR T-Cell...
Jennifer Trowbridge and her team reveal the molecular signaling pathway most associated with clonal hematopoiesis and how blocking a...
Guangwen “Gary” Ren's new research shows that the structural cells in the lung (fibroblasts) drive myeloid cell dysfunction to create a...
Eric Wang joins the JAX faculty to devise new strategies to overcome the development of drug resistance in cancer.
Roel Verhaak has joined the global Cancer Grand Challenges team, receiving $25M to take on the challenge of extrachromosomal...
I study complexity in a variety of biomedical fields through the application of translational science principles and computational...
The Jackson Laboratory announced today that it will take its cornerstone genomic tumor board program to oncologists across the nation as...
Investigating mechanisms of drug resistance in hematological malignancies with the main goal to develop new therapeutic strategies and...
A team led by JAX's Edison Liu and Francesca Menghi used patient data, patient-derived xenograft (PDX) mouse models, and engineered cancer...
Bispecific T cell engagers (BiTE) are a new immuno-oncology tool to fight cancer. Researchers at Memorial Sloan Kettering recently...
Researchers at MD Anderson Cancer Center utilize the MaFIA transgenic mouse to deplete tumor-infiltrating macrophages and reduce tumor...
Professor Carol Bult, Ph.D., investigates relationships between genes, cancer, pain and other health issues.
Rebecca Edwardson's priorities changed, when the former model's life was sidetracked by an unexpected foe: cancer.
Learn about the importance of human immune cells in maintaining the microenvironment and original genetic expression profile of patient...